A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris.
Taylor
S H
SH
Department of Medical Cardiology, General Infirmary Leed, England.
Lee
P
P
Jackson
N
N
Cocco
G
G
D000328:Adult; D000368:Aged; D017311:Amlodipine; D000787:Angina Pectoris / Q000188:drug therapy*; D002121:Calcium Channel Blockers; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D005082:Physical Exertion; D010919:Placebos; D013997:Time Factors
D002121:Calcium Channel Blockers; D010919:Placebos; D017311:Amlodipine; D005996:Nitroglycerin; D009543:Nifedipine